Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

TRIM58 Restrains Intestinal Mucosal Inflammation by Negatively Regulating TLR2 in Myeloid Cells.

Eyking A, Ferber F, Köhler S, Reis H, Cario E.

J Immunol. 2019 Sep 15;203(6):1636-1649. doi: 10.4049/jimmunol.1900413. Epub 2019 Aug 5.

2.

Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects. 1981.

Brunner DB, Desponds G, Biollaz J, Keller I, Ferber F, Gavras H, Brunner HR, Schelling JL.

Br J Clin Pharmacol. 2004 Dec;58(7):S778-84; discussion S785-7. No abstract available.

3.

[Glass ionomer cement as dental filling material].

Ferber F, Tanács A.

Fogorv Sz. 1990 May;83(5):129-32. Review. Hungarian. No abstract available.

PMID:
2192922
4.

Pharmacokinetics of imipenem and cilastatin in volunteers.

Rogers JD, Meisinger MA, Ferber F, Calandra GB, Demetriades JL, Bland JA.

Rev Infect Dis. 1985 Jul-Aug;7 Suppl 3:S435-46.

PMID:
3863219
5.

Disposition of radiolabeled imipenem and cilastatin in normal human volunteers.

Norrby SR, Rogers JD, Ferber F, Jones KH, Zacchei AG, Weidner LL, Demetriades JL, Gravallese DA, Hsieh JY.

Antimicrob Agents Chemother. 1984 Nov;26(5):707-14.

6.

Pharmacokinetics of imipenem in healthy volunteers.

Norrby SR, Björnegård B, Ferber F, Jones KH.

J Antimicrob Chemother. 1983 Dec;12 Suppl D:109-24.

PMID:
6583194
7.

Urinary recovery of N-formimidoyl thienamycin (MK0787) as affected by coadministration of N-formimidoyl thienamycin dehydropeptidase inhibitors.

Norrby SR, Alestig K, Björnegård B, Burman LA, Ferber F, Huber JL, Jones KH, Kahan FM, Kahan JS, Kropp H, Meisinger MA, Sundelof JG.

Antimicrob Agents Chemother. 1983 Feb;23(2):300-7.

8.

Pharmacokinetics and tolerance of N-formimidoyl thienamycin (MK0787) in humans.

Norrby SR, Alestig K, Ferber F, Huber JL, Jones KH, Kahan FM, Meisinger MA, Rogers JD.

Antimicrob Agents Chemother. 1983 Feb;23(2):293-9.

9.

Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects.

Brunner DB, Desponds G, Biollaz J, Keller I, Ferber F, Gavras H, Brunner HR, Schelling JL.

Br J Clin Pharmacol. 1981 May;11(5):461-7.

10.

Three new long-acting converting-enzyme inhibitors: relationship between plasma converting-enzyme activity and response to angiotensin I.

Biollaz J, Burnier M, Turini GA, Brunner DB, Porchet M, Gomez HJ, Jones KH, Ferber F, Abrams WB, Gavras H, Brunner HR.

Clin Pharmacol Ther. 1981 May;29(5):665-70.

PMID:
6260419

Supplemental Content

Loading ...
Support Center